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ndothelial tight junctions (TJs)* are an important
functional part of the blood-brain barrier (BBB). In
this issue, Nitta et al. (2003) demonstrate that clau-
din-5, a transmembrane protein of TJs, is a critical deter-
minant of BBB permeability in mice. Unexpectedly,
knockout of claudin-5 did not result in a general break-
down of TJs but in a selective increase in paracellular per-
meability of small molecules. This suggests that the BBB
can be manipulated to allow selective diffusion of small
molecules and makes claudin-5 a possible target for the
development of drugs for this purpose.
 
The BBB maintains the neural microenvironment by forming a
tight barrier between the blood and the brain. The BBB is
primarily formed by brain endothelial cells (BECs) lining the
microvascular system (Wolburg and Lippoldt, 2002). BECs
form a tight seal but also mediate selective transcellular
transport of nutrients and other essential components into
the brain, and efflux of potentially toxic metabolites from the
brain (Abbott, 2002). Nonspecific transendothelial transport
of soluble components (i.e., transport that is not mediated by
specific transporters) across endothelia can occur along two
routes: a transcellular route, which may be mediated by vesicu-
lar transport, and a paracellular route along a pathway between
neighboring cells. Brain capillaries allow little nonspecific
transendothelial transport since they exhibit only very low
rates of fluid phase transcytosis, and the paracellular route
between individual BECs is sealed by TJs that are much
tighter than in peripheral microvessels. Hence, TJs are a critical
determinant of the permeability properties of the BBB. Since
many potentially beneficial drugs are inactive because they
are unable to cross the BBB, much effort has been directed
toward the understanding of TJs of BECs to identify molecular
E
 
mechanisms that could be manipulated to enhance drug
delivery across the BBB.
In this issue, Shoichiro Tsukita’s group (Nitta et al., 2003)
reports the identification of claudin-5 as a critical regulator of
BEC permeability. They show that knockout of claudin-5 in
mice resulted in leakage of tracers from the blood into the brain,
although based on electron micrographs of ultrathin sections
and immunofluorescence TJs still formed and appeared to be
largely intact. Such mutant mice developed normally but
died a few hours after birth, which may or may not have been
due to the BBB defect. The absence of claudin-5 altered the
junctional properties so that they functioned like a molecular
sieve, allowing tracer diffusion in a size-selective manner,
but it did not cause nonspecific leakage of plasma compo-
nents into the brain. This was surprising for two reasons.
First, claudin-5 had been believed to be the main structural
transmembrane component of BEC TJs; hence, its absence
was widely expected to result in evident defects in TJ assembly
and a general breakdown of the junctional barrier. Second, the
size-selective permeability properties in the absence of claudin-5
suggest that BECs have the capability to allow size-selective
diffusion of tracers across TJs similar to many epithelial
cells. This is an exciting observation since it suggests that it
might be possible to manipulate BEC TJs in a manner that
results in a transient selective increase in the permeability for
small molecules, permitting small drugs to cross the BBB
without complete disruption of the junctional barrier.
How might selective permeability be mediated and regu-
lated? In principal, BEC TJs have a similar architecture to
those of epithelial cells (Dejana et al., 2000; Tsukita et al.,
2001). TJs contain different types of transmembrane proteins,
such as junctional adhesion molecules and the polytopic
proteins occludin and claudins. These transmembrane com-
ponents are linked via multiple adaptor proteins (i.e., proteins
with multiple protein–protein interaction motifs such as the
ZO or MAGI proteins) to the actin cytoskeleton and various
signaling components, such as protein kinases and GTP-
binding proteins. Claudins appear to be the main structural
transmembrane proteins of TJs and are major components of
the typical TJ-associated intramembrane strands seen in
freeze-fracture replicas (Tsukita et al., 2001). Since only two
claudins are known to be expressed by BECs, claudin-5 and
-12, it was unexpected that knockout of claudin-5 did not
have a major effect on TJ morphology. However, it could be
that the absence of claudin-5 was compensated by up-regula-
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tion of the expression of another claudin. Additionally, clau-
din-5 deficiency might cause minor morphological changes
that can only be visualized by freeze-fracture EM. Neverthe-
less, removal or addition of a claudin in cells that express mul-
tiple claudin family members does not generally have drastic
morphological consequences on TJs, suggesting that the abso-
lute amount of available claudin protein is not a critical deter-
minant of junction biogenesis.
Removal or addition of claudins generally does affect the
permeability properties of TJs. Claudins have mainly been
linked to selective ion permeability. A prominent example is
claudin-16/paracellin-1, which is responsible for paracellular
flux of Mg and Ca in the kidney and is mutated in patients
with familial hypomagnesemia-hypercalciuria (i.e., renal Mg
wasting) (Simon et al., 1999). Therefore, it is thought that
claudins form paracellular pores or channels that mediate se-
lective ion permeability (Anderson, 2001; Tsukita et al.,
2001). According to this model, the types of claudins that
constitute these channels determine their ion selectivity. On
the other hand, removal or addition of a claudin in the skin
resulted in dehydration and disruption of the epidermal bar-
rier, suggesting that claudins do not only affect ion perme-
ability (Furuse et al., 2002; Turksen and Troy, 2002).
Since removal of claudin-5 did not seem to inhibit junc-
tion formation and since it resulted in a size-selective increase
in permeability, it is unlikely that this phenotype was caused
by gaps in the BBB, but rather likely it was caused by the ac-
tivation of a mechanism that mediates size-selective paracel-
lular diffusion. Presently, we do not know how this works,
but as proposed for epithelia, such a mechanism may involve
a series of diffusion barriers that contain fluctuating pores or
channels that are formed by other claudin family members
and/or occludin (Claude, 1978; Cereijido et al., 1989; Balda
and Matter, 2000). The latter protein, occludin, is also a
polytopic transmembrane protein like the claudins and is as-
sociated with epithelial and endothelial TJs (Furuse et al.,
1993). Experiments with cultured epithelial cells demon-
strated that occludin regulates size-selective paracellular diffu-
sion of hydrophilic molecules (Balda and Matter, 2000). In
BECs, claudin-5 might normally associate with and inhibit
such a diffusion system, and therefore its removal results in
increased size-selective paracellular permeability.
How could such a permeation mechanism be exploited for
the development of therapies to manipulate the BBB? The pos-
sibility suggested by Nitta et al. (2003) is to target claudin-5. It
might be possible to remove or inactivate claudin-5 tempo-
rarily from TJs of BECs using, for example, peptides that com-
pete with its extracellular interactions. A similar approach was
used to remove occludin from TJs in cultured epithelia (Wong
and Gumbiner, 1997). An alternative tool is 
 
Clostridium
 
 per-
fringens enterotoxin, which binds and removes claudin-4 from
epithelial TJs (Sonoda et al., 1999). One could engineer deriv-
atives of the enterotoxin that are specific for claudin-5 and
could therefore be used to permeabilize endothelial TJs. It
could be, however, that in vivo removal of a transmembrane
protein has too drastic an effect on permeability to be used for
drug delivery; therefore, one may have to think of ways to
modulate the activity of junctional components involved in the
regulation of permeability in a more subtle manner. One possi-
bility is to target occludin: it has been proposed that phosphor-
ylation of its regulatory COOH-terminal cytoplasmic domain
 
regulates paracellular permeability of endothelia (Hirase et al.,
2001). Alternatively, it might be simpler to manipulate one of
the intracellular signaling components that regulate paracellu-
lar diffusion, such as the guanine nucleotide exchange factor
GEF-H1, a recently identified TJ-associated activator of RhoA
(Benais-Pont et al., 2003; Matter and Balda, 2003). Although
more research is needed to develop and validate such reagents
and therapies, the study by Nitta et al. (2003) provides a signif-
icant advance toward a molecular understanding of the BBB
and its regulation, and demonstrates that BBB permeability
can be manipulated in a selective manner.
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